These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32705968)

  • 1. The sirtuin inhibitor cambinol reduces intracellular glucosylceramide with ceramide accumulation by inhibiting glucosylceramide synthase.
    Ishibashi Y; Ito M; Hirabayashi Y
    Biosci Biotechnol Biochem; 2020 Nov; 84(11):2264-2272. PubMed ID: 32705968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glucosylceramide synthesis by Golgi-localized phosphoinositide.
    Ishibashi Y; Ito M; Hirabayashi Y
    Biochem Biophys Res Commun; 2018 May; 499(4):1011-1018. PubMed ID: 29627573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive method for determining UDP-glucose: ceramide glucosyltransferase (UGCG) activity in biological samples using deuterated glucosylceramide as acceptor substrate.
    Cas MD; Casati S; Roda G; Pablo Sardi S; Paroni R; di Fonzo A; Trinchera M
    Glycobiology; 2023 Mar; 33(2):88-94. PubMed ID: 36504340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased glucosylceramide production leads to decreased cell energy metabolism and lowered tumor marker expression in non-cancerous liver cells.
    Wegner MS; Schömel N; Olzomer EM; Trautmann S; Olesch C; Byrne FL; Brüne B; Gurke R; Ferreirós N; Weigert A; Geisslinger G; Hoehn KL
    Cell Mol Life Sci; 2021 Nov; 78(21-22):7025-7041. PubMed ID: 34626204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sirtuin inhibitor cambinol impairs MAPK signaling, inhibits inflammatory and innate immune responses and protects from septic shock.
    Lugrin J; Ciarlo E; Santos A; Grandmaison G; dos Santos I; Le Roy D; Roger T
    Biochim Biophys Acta; 2013 Jun; 1833(6):1498-510. PubMed ID: 23499872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
    Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides.
    Sutter CH; Azim S; Wang A; Bhuju J; Simpson AS; Uberoi A; Grice EA; Sutter TR
    J Invest Dermatol; 2023 Oct; 143(10):1964-1972.e4. PubMed ID: 37004877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycosphingolipid biosynthesis reverts multidrug resistance by differentially modulating ABC transporters in chronic myeloid leukemias.
    Salustiano EJ; da Costa KM; Freire-de-Lima L; Mendonça-Previato L; Previato JO
    J Biol Chem; 2020 May; 295(19):6457-6471. PubMed ID: 32229586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
    Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
    PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucosylceramide in T cells regulates the pathology of inflammatory bowel disease.
    Komuro M; Nagane M; Endo R; Nakamura T; Miyamoto T; Niwa C; Fukuyama T; Harashima H; Aihara N; Kamiie J; Suzuki R; Yamashita T
    Biochem Biophys Res Commun; 2022 Apr; 599():24-30. PubMed ID: 35168060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity.
    Medda F; Russell RJ; Higgins M; McCarthy AR; Campbell J; Slawin AM; Lane DP; Lain S; Westwood NJ
    J Med Chem; 2009 May; 52(9):2673-82. PubMed ID: 19419202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
    Barnes S; Xu YH; Zhang W; Liou B; Setchell KD; Bao L; Grabowski GA; Sun Y
    PLoS One; 2014; 9(12):e116023. PubMed ID: 25551612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes.
    Heltweg B; Gatbonton T; Schuler AD; Posakony J; Li H; Goehle S; Kollipara R; Depinho RA; Gu Y; Simon JA; Bedalov A
    Cancer Res; 2006 Apr; 66(8):4368-77. PubMed ID: 16618762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipocytes harbor a glucosylceramide biosynthesis pathway involved in iNKT cell activation.
    Rakhshandehroo M; van Eijkeren RJ; Gabriel TL; de Haar C; Gijzel SMW; Hamers N; Ferraz MJ; Aerts JMFG; Schipper HS; van Eijk M; Boes M; Kalkhoven E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1157-1167. PubMed ID: 31051284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated Protein Kinase Suppresses Biosynthesis of Glucosylceramide by Reducing Intracellular Sugar Nucleotides.
    Ishibashi Y; Hirabayashi Y
    J Biol Chem; 2015 Jul; 290(29):18245-18260. PubMed ID: 26048992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid B suppresses hepatic fibrosis by inhibiting ceramide glucosyltransferase in hepatic stellate cells.
    Li ZB; Jiang L; Ni JD; Xu YH; Liu F; Liu WM; Wang SG; Liu ZQ; Wang CY
    Acta Pharmacol Sin; 2023 Jun; 44(6):1191-1205. PubMed ID: 36627345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme.
    Hashimoto N; Matsumoto I; Takahashi H; Ashikawa H; Nakamura H; Murayama T
    Neuropharmacology; 2016 Nov; 110(Pt A):458-469. PubMed ID: 27539961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation of epidermal keratinocytes is dependent on glucosylceramide:ceramide processing.
    Amen N; Mathow D; Rabionet M; Sandhoff R; Langbein L; Gretz N; Jäckel C; Gröne HJ; Jennemann R
    Hum Mol Genet; 2013 Oct; 22(20):4164-79. PubMed ID: 23748427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of pyrazolone and isoxazol-5-one cambinol analogues as sirtuin inhibitors.
    Mahajan SS; Scian M; Sripathy S; Posakony J; Lao U; Loe TK; Leko V; Thalhofer A; Schuler AD; Bedalov A; Simon JA
    J Med Chem; 2014 Apr; 57(8):3283-94. PubMed ID: 24697269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The synthetic pathway for glucosylsphingosine in cultured fibroblasts.
    Yamaguchi Y; Sasagasako N; Goto I; Kobayashi T
    J Biochem; 1994 Sep; 116(3):704-10. PubMed ID: 7852294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.